PT Darya-Varia Laboratoria Tbk ("Darya-Varia" or "the Company") is a long-established pharmaceutical company in Indonesia that first commenced its operations in 1976. Upon becoming a public company in 1994, it acquired PT Pradja Pharin (Prafa) in 1995, and proceeded to develop a wide range of Prescription and Consumer Health products. In July 2014, Darya-Varia merged with Prafa.Darya-Varia operates two world-class manufacturing facilities, one in Gunung Putri and one in Citeureup, Bogor, both of which are ASEAN current Good Manufacturing Practice (cGMP) certified. The two plants are focused on manufacturing the Company's own brands, as well as toll manufacturing products for national and multinational principals, both for local and export markets.The Darya-Varia Plant in Gunung Putri specializes in manufacturing soft gelatin capsules and liquid products, while the Darya-Varia Plant in Citeureup concentrates on the manufacturing of sterile injections and solids. The Company also toll manufactures with its affiliate, PT Medifarma Laboratories, at Cimanggis Plant, Depok. In 2013, the Company obtained halal certification for NATUR-E and HOBAT Capsules, its animal based gelatin products, marking a first halal certified supplement for a pharmaceutical company in Indonesia.In line with its mission to "build a healthier Indonesia one person at a time", Darya-Varia produces high quality products for both Consumer Health and Ethical product lines, building strong, respected brands that are recognized throughout Indonesia. By following a consistent and relationship-driven engagement approach, the Company is moving to achieve its vision to be a top-five pharmaceutical company in Indonesia.Currently 92.66% of Darya-Varia shares is owned by Blue Sphere Singapore Pte. Ltd. (BSSPL), an affiliate of United Laboratories, Inc. (Unilab).Unilab, the Philippines' largest pharmaceutical company, was established in 1945 and now has a large network of Asian affiliates including operations in Indonesia, Vietnam, Myanmar, Thailand, Malaysia, Singapore, Laos, Cambodia and China.
PT Darya-Varia Laboratoria Tbk ("Darya-Varia" or "the Company") is a long-established pharmaceutical company in Indonesia that first commenced its operations in 1976. Upon becoming a public company in 1994, it acquired PT Pradja Pharin (Prafa) in 1995, and proceeded to develop a wide range of Prescription and Consumer Health products. In July 2014, Darya-Varia merged with Prafa.Darya-Varia operates two world-class manufacturing facilities, one in Gunung Putri and one in Citeureup, Bogor, both of which are ASEAN current Good Manufacturing Practice (cGMP) certified. The two plants are focused on manufacturing the Company's own brands, as well as toll manufacturing products for national and multinational principals, both for local and export markets.The Darya-Varia Plant in Gunung Putri specializes in manufacturing soft gelatin capsules and liquid products, while the Darya-Varia Plant in Citeureup concentrates on the manufacturing of sterile injections and solids. The Company also toll manufactures with its affiliate, PT Medifarma Laboratories, at Cimanggis Plant, Depok. In 2013, the Company obtained halal certification for NATUR-E and HOBAT Capsules, its animal based gelatin products, marking a first halal certified supplement for a pharmaceutical company in Indonesia.In line with its mission to "build a healthier Indonesia one person at a time", Darya-Varia produces high quality products for both Consumer Health and Ethical product lines, building strong, respected brands that are recognized throughout Indonesia. By following a consistent and relationship-driven engagement approach, the Company is moving to achieve its vision to be a top-five pharmaceutical company in Indonesia.Currently 92.66% of Darya-Varia shares is owned by Blue Sphere Singapore Pte. Ltd. (BSSPL), an affiliate of United Laboratories, Inc. (Unilab).Unilab, the Philippines' largest pharmaceutical company, was established in 1945 and now has a large network of Asian affiliates including operations in Indonesia, Vietnam, Myanmar, Thailand, Malaysia, Singapore, Laos, Cambodia and China.
PT Darya-Varia Laboratoria Tbk ("Darya-Varia" or "the Company") is a long-established pharmaceutical company in Indonesia that first commenced its operations in 1976. Upon becoming a public company in 1994, it acquired PT Pradja Pharin (Prafa) in 1995, and proceeded to develop a wide range of Prescription and Consumer Health products. In July 2014, Darya-Varia merged with Prafa.Darya-Varia operates two world-class manufacturing facilities, one in Gunung Putri and one in Citeureup, Bogor, both of which are ASEAN current Good Manufacturing Practice (cGMP) certified. The two plants are focused on manufacturing the Company's own brands, as well as toll manufacturing products for national and multinational principals, both for local and export markets.The Darya-Varia Plant in Gunung Putri specializes in manufacturing soft gelatin capsules and liquid products, while the Darya-Varia Plant in Citeureup concentrates on the manufacturing of sterile injections and solids. The Company also toll manufactures with its affiliate, PT Medifarma Laboratories, at Cimanggis Plant, Depok. In 2013, the Company obtained halal certification for NATUR-E and HOBAT Capsules, its animal based gelatin products, marking a first halal certified supplement for a pharmaceutical company in Indonesia.In line with its mission to "build a healthier Indonesia one person at a time", Darya-Varia produces high quality products for both Consumer Health and Ethical product lines, building strong, respected brands that are recognized throughout Indonesia. By following a consistent and relationship-driven engagement approach, the Company is moving to achieve its vision to be a top-five pharmaceutical company in Indonesia.Currently 92.66% of Darya-Varia shares is owned by Blue Sphere Singapore Pte. Ltd. (BSSPL), an affiliate of United Laboratories, Inc. (Unilab).Unilab, the Philippines' largest pharmaceutical company, was established in 1945 and now has a large network of Asian affiliates including operations in Indonesia, Vietnam, Myanmar, Thailand, Malaysia, Singapore, Laos, Cambodia and China.